Covered recipient · General Payments record
YOUNG OAK K PRYOR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,249.80
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $527.53 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.25 | 13 |
| Neuronetics, Inc. | $187.76 | 4 |
| Supernus Pharmaceuticals, Inc. | $32.95 | 2 |
| Alkermes, Inc. | $25.03 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.38 | 1 |
| Neurocrine BioSciences, Inc. | $19.89 | 1 |
| ITI, Inc. | $16.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.12 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454004 | CMS |
| ABBVIE INC. | $2.10 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454006 | CMS |
| ABBVIE INC. | $6.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454008 | CMS |
| ABBVIE INC. | $20.44 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454010 | CMS |
| ABBVIE INC. | $25.05 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454012 | CMS |
| ABBVIE INC. | $29.13 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454014 | CMS |
| ABBVIE INC. | $27.80 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454016 | CMS |
| ABBVIE INC. | $28.26 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454018 | CMS |
| ABBVIE INC. | $17.78 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454020 | CMS |
| ABBVIE INC. | $4.03 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454022 | CMS |
| ABBVIE INC. | $22.66 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454024 | CMS |
| ABBVIE INC. | $10.57 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454026 | CMS |
| ABBVIE INC. | $22.58 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454028 | CMS |
| Alkermes, Inc. | $25.03 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120624600 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143632875 | CMS |
| Neurocrine Biosciences, Inc. | $19.89 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150980356 | CMS |
| Neuronetics, Inc. | $52.78 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073310620 | CMS |
| Neuronetics, Inc. | $41.10 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073310638 | CMS |
| Neuronetics, Inc. | $52.78 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073311342 | CMS |
| Neuronetics, Inc. | $41.10 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073311360 | CMS |
| Supernus Pharmaceuticals, Inc. | $15.32 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147842363 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.63 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147820433 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.38 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137848230 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.